Allostery Investments LP 13D/13G Filings for ARCA biopharma, Inc. (ABIO)

Allostery Investments LP 13D and 13G filings for ARCA biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-04-15
5:29 pm
Purchase
2024-04-0313GARCA biopharma, Inc.
ABIO
Allostery Investments LP88,751
7.300%
88,751increase
(New Position)
Filing